Dr. rer. nat. Katja Klausz
Facts
Phone:
+49-431-500-22789
E-Mail:
katja.klausz[at]uksh.de
Affiliations:
Division of Antibody-based Immunotherapy / University Medical Center Schleswig-Holstein, Campus Kiel, Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
Address:
Rosalind-Franklin-Str. 12, 24105 Kiel
Curriculum vitae
Research Experience
| since 05/2022 | Group leader in the Divison of Antibody-Based Immunotherapy (leader: Prof. Dr. Matthias Peipp), Clinic for Internal Medicine II at the University Medical Center Schleswig-Holstein, Campus Kiel New immunotherapies for the treatment of multiple myeloma |
| since 01/2011 | Project leader/scientist in the research group of Prof. Peipp at the Division for Stem Cell and Immunotherapy of the Clinic for Internal Medicine II of the UKSH, Campus Kiel Development and characterization of antibodies and derived molecules for the therapy of hemato-oncological diseases |
| 06/2009 – 12/2010 | Project leader/scientist in the research group of Prof. Valerius at the Divison for Stem Cell and Immunotherapy, UKSH, Campus Kiel Industry-sponsored project (Genmab) to evaluate effector functions of human epidermal growth factor receptor (EGFR) antibodies for solid tumors |
| 11/2005 – 05/2009 | Multiple research stays of several months at the A.I. Virtanen Institute for Molecular Sciences in Kuopio, Finland |
Education/Training
| 11/2005 – 05/2009 | Research assistant (PhD student) at the Clinic for Internal Medicine of the UKSH, Campus Kiel, and scientific PhD student in the Department of Cell Biology of the Faculty of Mathematics and Natural Sciences of the Christian-Albrechts-Universität Kiel (CAU) |
| 0/1999 – 11/2005 | Degree in biology, University of Rostock Major: microbiology Minor: molecular biology/genetics, immunology, medical microbiology |
Fundings
| 2022 | Intramural funding (for habilitation) of the medical faculty, CAU Kiel |
| 2020 – 2021 | Bundesministerium für Bildung und Forschung (BMBF) GO-Bio initial |
| 2016 – 2019 | Else Kröner-Fresenius-Stiftung (EKFS) |
| 2015 – 2016 | Werner und Klara Kreitz-Stiftung |
| 2014 – 2015 | Intramural funding (junior funding) of the medical faculty, CAU Kiel |
| since 2017 | Several industrial-funded projects |
Other
| Training as a representative according to the gene technology act (§ 15 GenTSV) |
| Qualification for the management of animal experimentation projects (FELASA C) |
